BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Treatment
10514 results:

  • 1. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
    Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
    Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer.
    Bang AS; Said JT; Hirner J; Rana J; Pugliese S; Wang JY; Zaba L; Zhao L; Doan L; Smith J; Kwong BY
    Support Care Cancer; 2024 May; 32(6):354. PubMed ID: 38750379
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hospitalization and mortality in Asian autoimmune bullous dermatosis patients: A 17-year retrospective study.
    Amonchaisakda N; Rujitharanawong C; Tuchinda P; Kulthanan K; Chularojanamontri L
    Exp Dermatol; 2024 May; 33(5):e15095. PubMed ID: 38742822
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Predicting the effectiveness of organ-preserving treatment of choroidal melanoma using optical coherence tomography data].
    Stoyukhina AS
    Vestn Oftalmol; 2024; 140(2. Vyp. 2):16-20. PubMed ID: 38739126
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long-term survival after anti-PD-1 discontinuation in advanced cutaneous squamous cell carcinoma (cSCC): a proof of concept of benefit of concomitant cemiplimab and radiotherapy.
    Bailly-Caillé B; Levard R; Kottler D; Dompmartin A; L'Orphelin JM
    Cancer Immunol Immunother; 2024 May; 73(7):118. PubMed ID: 38713217
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. An Explorative Study on Calcium Electroporation for Low-risk Basal Cell Carcinoma.
    Wiegell SR; Hendel K; Fuchs CSK; Gehl J; Vissing M; Bro SW; Troelsen JT; Jemec GBE; Haedersdal M
    Acta Derm Venereol; 2024 May; 104():adv19678. PubMed ID: 38712969
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A Comparative Analysis of Implant-sparing Plan
    Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
    In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hedgehog pathway inhibitors for locally advanced and metastatic basal cell carcinoma: A real-world single-center retrospective review.
    Patel S; Armbruster H; Pardo G; Archambeau B; Kim NH; Jeter J; Wu R; Kendra K; Contreras CM; Spaccarelli N; Dulmage B; Pootrakul L; Carr DR; Verschraegen C
    PLoS One; 2024; 19(4):e0297531. PubMed ID: 38687774
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Decoding dynamic interactions between EGFR-TKD and DAC through computational and experimental approaches: A novel breakthrough in lung melanoma treatment.
    Meher RK; Mir SA; Singh K; Mukerjee N; Nayak B; Kumer A; Zughaibi TA; Khan MS; Tabrez S
    J Cell Mol Med; 2024 May; 28(9):e18263. PubMed ID: 38685671
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mesenchymal stromal/stem cells promote intestinal epithelium regeneration after chemotherapy-induced damage.
    Yetkin-Arik B; Jansen SA; Varderidou-Minasian S; Westendorp B; Skarp KP; Altelaar M; Lindemans CA; Lorenowicz MJ
    Stem Cell Res Ther; 2024 Apr; 15(1):125. PubMed ID: 38679715
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Complications and Recurrences after Excision and Reconstruction of Eyelid Tumours.
    Balchev G
    Curr Oncol; 2024 Mar; 31(4):1713-1724. PubMed ID: 38668033
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Dermoscopic-Guided Shave Removal of Acquired Facial Melanocytic Nevi in Dark-skinned Individuals.
    Rezk AF; Touni AA
    Dermatol Surg; 2024 May; 50(5):434-438. PubMed ID: 38662517
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. skin Changes in Suspected Lyme Disease.
    Vržogić P; Perica A
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):225-228. PubMed ID: 38651851
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mycosis fungoides with large cell transformation (CD30+) and B-cell chronic lymphocytic leukemia.
    Petković M; Ilić I; Jurakić Tončić R; Radman-Livaja I; Čeović R
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):223-224. PubMed ID: 38651850
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cutaneous T-cell Lymphomas: A Single-center Retrospective Analysis.
    Kaemmerer T; Guertler A; Clanner-Engelshofen BM; Fuchs C; French LE; Reinholz M
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):184-190. PubMed ID: 38651844
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland.
    Thet Z; Lam AK; Ng SK; Aung SY; Han T; Ranganathan D; Newsham S; Borg J; Pepito C; Khoo TK
    Aust J Rural Health; 2024 Apr; 32(2):249-262. PubMed ID: 38646861
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The role of thymic stromal lymphopoietin in cutaneous disorders.
    Jafari AJ; Rivera M; Hebert AA
    Arch Dermatol Res; 2024 Apr; 316(5):123. PubMed ID: 38630260
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Fragile hands: targeting nonmelanoma skin cancer on older hands using 595 nm pulsed dye laser.
    Herron ED; Snyder AM; Hull CM; LoBello S; Herron MD
    Lasers Med Sci; 2024 Apr; 39(1):101. PubMed ID: 38630146
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. skin cancer Risk of Narrow-Band UV-B (TL-01) Phototherapy: A Multi-Center Registry Study with 4,815 Patients.
    Åkerla P; Pukkala E; Helminen M; Korhonen N; Karppinen T
    Acta Derm Venereol; 2024 Apr; 104():adv39927. PubMed ID: 38629891
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. skin cancer occurrence: single-center experiences from period 2020-2022.
    Łaziński Ł; Koziej M; Antoszewski B; Fijałkowska M
    Pol Przegl Chir; 2023 Oct; 96(2):26-30. PubMed ID: 38629283
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 526.